Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 6 of 6

David Dexter

Difficulty in defending second medical use patents can cause pharmaceutical companies to be nervous about investing in this type of research, says David Dexter, deputy director of research at Parkinson’s UK

Source  David Dexter